Nuglow
NDC Package 65113-8503-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Nuglow is after cleansing, apply liberally to face daily. Marketed by G.s. Cosmeceutical Usa, Inc., this product is identified by NDC 65113-8503 and is authorized under FDA application part352.

Identification & Billing

NDC Package Code
65113-8503-3
Package Description
34 g in 1 JAR
Product Code
65113-8503
11-Digit Billing Format
65113850303

Clinical Specifications

Proprietary Name
Nuglow Daytime Therapy With Spf 15
Dosage Form
-
Usage Information
After cleansing, apply liberally to face daily. Apply evenly before sun exposure. Reapply as needed after towel drying, swimming or perspiring.

Regulatory & Marketing

Labeler Name
G.s. Cosmeceutical Usa, Inc.
FDA Application #
part352
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
10-15-2010
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65113-8503-3 identifies a specific commercial package of 34 g in 1 jar of Nuglow Daytime Therapy With Spf 15, labeled by G.s. Cosmeceutical Usa, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by G.s. Cosmeceutical Usa, Inc. on October 15, 2010. The current certification is valid through December 31, 2017.

How is this G.s. Cosmeceutical Usa, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65113850303. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
65113-8503-3
11-Digit CMS (5-4-2)
65113-8503-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.